Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
abrdn Healthcare InvestorsHQH -0.10%48 PS Ratio is 5.52 as of Jul. 16, 2026, which is 26% below its 10-year median of 7.42. GuruFocus rates HQH with a GF Score™ of 48/100 and a GF Value™ of $50.26 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,410 Asset Management companies, abrdn Healthcare Investors ranks better than 59.65% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, abrdn Healthcare Investors's share price is $21.02.
abrdn Healthcare Investors's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $3.81. Hence, abrdn Healthcare Investors's PS Ratio for today is 5.52.
Warning Sign:
abrdn Healthcare Investors stock PS Ratio (=12.91) is close to 1-year high of 13.5.
The historical rank and industry rank for abrdn Healthcare Investors's PS Ratio or its related term are showing as below:
HQH'
s PS Ratio Range Over the Past 10 Years
Min: 3.61 Med: 7.42 Max: 17.11
Current: 5.51
During the past 9 years, abrdn Healthcare Investors's highest PS Ratio was 17.11. The lowest was 3.61. And the median was 7.42.
HQH's PS Ratio is ranked better than 59.65% of 1410
companies
in the Asset Management industry
Industry Median: 7.3
vs HQH: 5.51
During the past 9 years, abrdn Healthcare Investors's highest 3-Year average Revenue per Share Growth Rate was 31.10% per year. The lowest was -41.00% per year. And the median was 0.20% per year.
Back to Basics: PS Ratio
abrdn Healthcare Investors (NYSE:HQH) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
abrdn Healthcare Investors PS Ratio Related Terms
abrdn Healthcare Investors PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, abrdn Healthcare Investors's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
abrdn Healthcare Investors PS Ratio vs Asset Management Industry
For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's PS Ratio distribution charts can be found below:
* The bar in red indicates where abrdn Healthcare Investors's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
abrdn Healthcare Investors's Share Price of today is $21.02.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. abrdn Healthcare Investors's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $3.81.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
abrdn Healthcare Investors (HQH) has a PS Ratio of 5.52 as of Jul. 16, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on abrdn Healthcare Investors and its competitors. This is 26% below median its historical median of 7.42. Over the past decade, abrdn Healthcare Investors' PS Ratio has ranged from 3.61 to 17.11. According to the industry distribution chart, abrdn Healthcare Investors ranks #569 out of 1410 companies in the Asset Management industry, placing it in the top 40.4%.
Is abrdn Healthcare Investors' PS Ratio too high?
abrdn Healthcare Investors' current PS Ratio of 5.52 is 26% below median its 10-year median of 7.42. Over the past 10 years, this metric has ranged from a low of 3.61 to a high of 17.11. The Asset Management industry median PS Ratio is 7.30. abrdn Healthcare Investors' value of 5.52 is 24.4% below this industry median. Based on the distribution chart, abrdn Healthcare Investors ranks #569 out of 1410 companies in the Asset Management industry, which is above the industry midpoint. Overall, abrdn Healthcare Investors has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does abrdn Healthcare Investors' PS Ratio compare to DSL and NMZ?
According to the Asset Management industry distribution chart, abrdn Healthcare Investors ranks #569 out of 1410 companies for PS Ratio. This puts abrdn Healthcare Investors in the upper half of its industry. The industry median PS Ratio is 7.30. abrdn Healthcare Investors' value of 5.52 is 24.4% below this benchmark. Historically, abrdn Healthcare Investors' own PS Ratio has ranged from 3.61 to 17.11 over the past decade. While the company's 10-year median is 7.42 vs. the industry median of 7.30, abrdn Healthcare Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for an Asset Management company?
The median PS Ratio among Asset Management companies is 7.30, based on 1,410 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. abrdn Healthcare Investors's current PS Ratio of 5.52 is 24.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on abrdn Healthcare Investors and its competitors. For the Asset Management industry, the median PS Ratio is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. abrdn Healthcare Investors's current PS Ratio is 5.52, which is 26% below median its own 10-year median of 7.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Healthcare Investors (HQH) is currently considered Possible Value Trap. The stock's GF Value™ is $50.26, compared to a current price of $21.02 — trading 58.2% below its estimated fair value. The current PS Ratio is 5.52, which is 26% below median its 10-year median of 7.42 and 24.4% below the Asset Management industry median of 7.30. abrdn Healthcare Investors' overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For abrdn Healthcare Investors (HQH), the current PS Ratio is 5.52 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is abrdn Healthcare Investors (HQH) Overvalued in 2026?
Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued.
The current stock price of $21.02 is trading 58.2% below its estimated GF Value™ of $50.26.
GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.
Key valuation signals for HQH:
PS Ratio: 5.52 (26% below median its 10-year median of 7.42)
GF Value™: $50.26 vs. price of $21.02 (58.2% below fair value)
Industry Position: 24.4% below the Asset Management median (#569 of 1410)
No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
48GF Score
Get the complete analysis for HQH
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HQH has been successfully added to your 
